ReviewFrontiers in immunology2026
Traditional Chinese medicine in sepsis-associated PICS: potential immunometabolic mechanisms and translational perspectives.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Persistent inflammation, immunosuppression, and catabolism syndrome (PICS) has emerged as an important contributor to long-term morbidity among survivors of sepsis. This syndrome is characterized by sustained immune dysregulation, metabolic disturbances, and progressive skeletal muscle wasting, reflecting a failure of coordinated recovery following severe infection. Although advances in critical care have improved early survival, effective strategies targeting the complex immunometabolic alterations underlying PICS remain limited. Traditional Chinese medicine (TCM) has increasingly been investigated as an adjunctive approach in critical care. Randomized clinical studies have reported potential benefits of several Chinese herbal injections in patients with sepsis, particularly Xuebijing injection, which has been associated with improvements in short-term clinical outcomes and inflammatory markers. Experimental studies further suggest that bioactive compounds contained in herbal formulations may influence multiple biological processes relevant to immune regulation and metabolic homeostasis. However, most available evidence has been derived from studies conducted during the acute phase of sepsis rather than the prolonged recovery phase in which PICS develops. In addition, the absence of a standardized diagnostic definition for PICS, together with variability in biomarker thresholds, diagnostic timing, and outcome measures across studies, limits comparability and may introduce heterogeneity in patient selection. These factors constrain the interpretation and generalizability of current findings. Accordingly, the potential role of TCM in PICS should be interpreted with caution. Rather than providing definitive therapeutic recommendations, this review critically synthesizes the currently available evidence, identifies important knowledge gaps, and proposes a conceptual framework to guide future mechanistic and translational studies in post-sepsis recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.